To present the current epidemiologic situation regarding hypertension's prevalence and control in Romania's adult population (revealed by SEPHAR II survey results) and to evaluate their tendency during the last 7 years (by comparing with the SEPHAR I survey results).
The two SEPHAR cross-sectional national surveys were conducted on a representative sample for the Romanian adult population (SEPHAR I: 2017 individuals aged 18–85 years, 45% response rate, SEPHAR II: 1975 individuals aged 18–80 years, 69% response rate), by means of questionnaire interview, blood pressure (BP) and anthropometric measurements during two study visits. Hypertension was defined as SBP at least 140 mmHg and/or DBP at least 90 mmHg at both study visits or previously diagnosed hypertension under current treatment. Controlled BP was defined as SBP less than 140 mmHg and DBP less than 90 mmHg in currently treated hypertensive individuals.
Prevalence of hypertension in Romanian is 40.41%, awareness of hypertension is 69.55%, with 59.15% hypertensive individuals under current treatment with a control rate of 25%. In the last 7 years, there has been a 10.7% decrease in hypertension's prevalence together with an increase by 57% in awareness of hypertension and an increase by 52% in treatment of hypertension, leading to almost doubling of the hypertension's control rate in all hypertensive individuals.
Although in the last 7 years, the tendency of hypertension's prevalence seems to be a descending one with an increasing trend in awareness, treatment and control of this condition, hypertension in Romania at this time still remains an ‘unsolved equation’.
Supplemental Digital Content is available in the text
aCardiology Department, Carol Davila University of Medicine and Pharmacy, Clinical Emergency Hospital
bCardiology Department, Carol Davila University of Medicine and Pharmacy, University Emergency Hospital
cInternal Medicine Department, Carol Davila University of Medicine and Pharmacy, Clinical Emergency Hospital, Bucharest
dMedical Cardiology Department, ’Gr.T. Popa’ University of Medicine and Pharmacy, Institute of Cardiovascular Diseases
eFirst Cardiology Department, Carol Davila University of Medicine and Pharmacy, Institute of Cardiovascular Diseases, Bucharest
fCardiology Department, ’Gr.T. Popa’ University of Medicine and Pharmacy, Clinical Hospital for Recovery Iaşi
gFirst Internal Medicine Department, ’Victor Babeş’ University of Medicine and Pharmacy, Municipal Emergency Hospital, Timisoara
hUniversity of Medicine and Pharmacy, Cardiology Center, Craiova
iCardiology Department, West University ‘Vasile Goldis’ Faculty of Medicine Arad, Emergency County Hospital, Baia Mare
jGeneral Practitioner Department, ’Victor Babeş’ University of Medicine and Pharmacy, Timisoara
kCardiology Department, Ovidius University Constanta – General Medicine Faculty, Clinical Emergency County Hospital, Constanta, Romania
*Maria Dorobanţu and Oana-Florentina T[Latin Small Letter a with Caron]utu contributed equally to the current article.
Correspondence to Professor Dr Maria Dorobanţu, Head of Cardiology Department, Clinical Emergency Hospital Bucharest, Calea Floreasca no. 8, sector 1, Bucharest 014461, Romania. Tel: +4021 5992264; fax: +4021 3170108; e-mail: firstname.lastname@example.org
Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure; CAA, centrally acting antihypertensive drug; CCB, calcium channel blocker; CV, cardiovascular; CVD, cardiovascular disease; DALY, disability adjusted life years; GP, general practitioner; HR, heart rate; HT, hypertension; RR, response rate; SEPHAR, Study for the Evaluation of Prevalence of Hypertension and Cardiovascular Risk in Romania
Received 15 November, 2012
Accepted 20 August, 2013
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).